Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Benjamin Steinberg

Concepts (410)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
128
2026
550
30.540
 Why?
Anticoagulants
50
2026
722
8.750
 Why?
Anti-Arrhythmia Agents
24
2026
142
6.380
 Why?
Stroke
36
2025
1256
5.840
 Why?
Catheter Ablation
25
2025
353
5.620
 Why?
Registries
37
2025
2385
3.860
 Why?
Patient Reported Outcome Measures
16
2024
488
3.740
 Why?
Heart Failure
28
2025
2323
3.720
 Why?
Warfarin
15
2023
170
3.300
 Why?
Heart Rate
15
2026
855
2.680
 Why?
Electrocardiography, Ambulatory
4
2024
64
2.640
 Why?
Hemorrhage
22
2026
809
2.480
 Why?
Sotalol
8
2025
13
2.480
 Why?
Defibrillators, Implantable
12
2025
382
2.390
 Why?
Thromboembolism
8
2019
125
2.360
 Why?
Aged
101
2026
25913
2.190
 Why?
Electric Countershock
8
2022
127
2.010
 Why?
Risk Assessment
29
2026
3671
1.930
 Why?
Treatment Outcome
61
2026
11679
1.920
 Why?
Cardiac Resynchronization Therapy
5
2022
63
1.690
 Why?
Stroke Volume
13
2025
651
1.670
 Why?
Amiodarone
5
2025
31
1.660
 Why?
Administration, Oral
21
2026
847
1.610
 Why?
Humans
173
2026
144759
1.610
 Why?
Coronary Artery Disease
10
2023
741
1.460
 Why?
Risk Factors
46
2026
10779
1.460
 Why?
Male
114
2026
72315
1.440
 Why?
Wearable Electronic Devices
3
2023
63
1.410
 Why?
Female
115
2026
78271
1.410
 Why?
Pacemaker, Artificial
5
2024
126
1.360
 Why?
Electrocardiography
10
2024
662
1.340
 Why?
Atrial Flutter
4
2026
45
1.310
 Why?
Middle Aged
73
2026
35875
1.300
 Why?
Aged, 80 and over
40
2026
8265
1.190
 Why?
Electrophysiologic Techniques, Cardiac
6
2024
84
1.180
 Why?
Quality of Life
14
2024
3185
1.170
 Why?
Atrial Appendage
3
2025
35
1.120
 Why?
Time Factors
25
2026
7173
1.050
 Why?
Disease Management
4
2020
645
1.030
 Why?
Arrhythmias, Cardiac
6
2024
361
1.020
 Why?
Practice Patterns, Physicians'
4
2025
1356
1.020
 Why?
Cardiac Electrophysiology
3
2024
21
1.000
 Why?
beta-Alanine
4
2014
23
1.000
 Why?
United States
36
2026
15966
1.000
 Why?
Vitamin K
5
2017
45
0.970
 Why?
Follow-Up Studies
20
2025
5408
0.950
 Why?
Prospective Studies
26
2025
7990
0.940
 Why?
Benzimidazoles
4
2014
190
0.910
 Why?
Comorbidity
13
2024
1658
0.900
 Why?
Utah
8
2026
81
0.900
 Why?
Bundle-Branch Block
2
2023
36
0.890
 Why?
Electric Power Supplies
1
2025
52
0.870
 Why?
Heart Atria
6
2024
144
0.840
 Why?
Cardiac Resynchronization Therapy Devices
3
2021
18
0.830
 Why?
Tricuspid Valve
1
2024
41
0.820
 Why?
Retrospective Studies
34
2026
17066
0.820
 Why?
Bundle of His
1
2023
19
0.800
 Why?
Heart Valve Prosthesis
2
2024
134
0.780
 Why?
Lithotripsy
1
2023
49
0.770
 Why?
Pyroptosis
1
2022
5
0.770
 Why?
Tachycardia, Paroxysmal
1
2022
8
0.740
 Why?
Survival Rate
11
2021
2089
0.720
 Why?
Coronary Artery Bypass
4
2013
268
0.700
 Why?
Rivaroxaban
4
2017
267
0.700
 Why?
Glycine
1
2022
187
0.690
 Why?
Cardiac Pacing, Artificial
5
2024
84
0.690
 Why?
Embolism
3
2021
48
0.680
 Why?
Heart Conduction System
3
2023
95
0.680
 Why?
Factor Xa Inhibitors
6
2020
187
0.680
 Why?
Patient Discharge
3
2024
983
0.660
 Why?
Hospitalization
10
2025
2433
0.660
 Why?
Scholarly Communication
1
2020
4
0.660
 Why?
Peer Influence
1
2020
14
0.650
 Why?
Decision Support Techniques
4
2025
456
0.620
 Why?
Clinical Trials as Topic
3
2024
1053
0.620
 Why?
Incidence
12
2025
2879
0.610
 Why?
Self-Assessment
1
2020
74
0.610
 Why?
Morpholines
3
2014
128
0.600
 Why?
Thiophenes
3
2014
128
0.590
 Why?
Workload
1
2020
170
0.570
 Why?
Myocardial Infarction
5
2019
1209
0.560
 Why?
Death, Sudden, Cardiac
2
2017
230
0.550
 Why?
Checklist
1
2019
107
0.540
 Why?
Pyridones
2
2017
199
0.540
 Why?
Dabigatran
5
2017
29
0.530
 Why?
Social Media
1
2020
171
0.520
 Why?
Length of Stay
4
2024
1337
0.520
 Why?
Biomedical Research
2
2021
710
0.510
 Why?
Brain Ischemia
2
2018
358
0.510
 Why?
Health Status
2
2020
836
0.510
 Why?
Heart Failure, Systolic
1
2017
27
0.500
 Why?
Off-Label Use
1
2016
49
0.490
 Why?
Blood Component Transfusion
1
2017
103
0.480
 Why?
Nervous System
1
2016
70
0.460
 Why?
Pyrazoles
2
2017
509
0.460
 Why?
Heparin, Low-Molecular-Weight
1
2015
36
0.460
 Why?
Infusions, Intravenous
3
2026
423
0.450
 Why?
Eligibility Determination
1
2015
68
0.440
 Why?
Therapy, Computer-Assisted
1
2015
64
0.440
 Why?
Dementia
3
2025
303
0.440
 Why?
Medicare
7
2022
886
0.440
 Why?
American Heart Association
2
2017
350
0.430
 Why?
Ventricular Function, Left
2
2022
541
0.430
 Why?
Cardiac Imaging Techniques
1
2014
24
0.430
 Why?
Critical Pathways
2
2013
108
0.420
 Why?
Practice Guidelines as Topic
6
2024
1560
0.410
 Why?
Cardiovascular Diseases
7
2024
2168
0.410
 Why?
Elective Surgical Procedures
1
2015
201
0.410
 Why?
Intracranial Hemorrhages
1
2014
100
0.400
 Why?
Cardiomyopathies
1
2017
338
0.400
 Why?
Electronic Health Records
5
2024
1173
0.400
 Why?
Blood Coagulation
1
2015
268
0.400
 Why?
Drug Administration Schedule
6
2020
779
0.390
 Why?
Guideline Adherence
3
2019
589
0.390
 Why?
Platelet Aggregation Inhibitors
4
2024
497
0.390
 Why?
Cerebral Hemorrhage
1
2014
120
0.390
 Why?
Gastrointestinal Hemorrhage
1
2014
136
0.390
 Why?
Predictive Value of Tests
8
2024
2115
0.380
 Why?
Dose-Response Relationship, Drug
5
2024
2027
0.370
 Why?
Antithrombins
4
2017
70
0.370
 Why?
Drug Dosage Calculations
3
2018
27
0.370
 Why?
Prognosis
10
2025
4282
0.360
 Why?
Natural Language Processing
4
2023
103
0.350
 Why?
Angioplasty, Balloon, Coronary
3
2007
157
0.350
 Why?
Hospitals, University
1
2012
176
0.350
 Why?
Critical Care
3
2016
695
0.350
 Why?
Proportional Hazards Models
6
2021
1325
0.350
 Why?
Prevalence
8
2025
2834
0.350
 Why?
Randomized Controlled Trials as Topic
8
2024
1720
0.340
 Why?
Patient Selection
1
2015
719
0.340
 Why?
Action Potentials
6
2025
506
0.340
 Why?
Heart Valve Prosthesis Implantation
2
2013
197
0.330
 Why?
Global Health
3
2019
401
0.320
 Why?
Hemodynamics
2
2026
1121
0.320
 Why?
Multivariate Analysis
6
2021
1539
0.320
 Why?
Valine
2
2021
80
0.320
 Why?
Echocardiography, Transesophageal
3
2017
133
0.320
 Why?
Age Factors
8
2025
3333
0.310
 Why?
Brain
1
2022
2933
0.310
 Why?
Aspirin
1
2013
399
0.310
 Why?
Triage
1
2012
249
0.300
 Why?
Aortic Valve Stenosis
1
2012
253
0.300
 Why?
Outpatients
3
2020
442
0.300
 Why?
Cause of Death
5
2024
471
0.290
 Why?
Fibrinolytic Agents
2
2013
291
0.290
 Why?
Heart Diseases
1
2012
349
0.290
 Why?
Hemostasis
2
2022
102
0.290
 Why?
Recovery of Function
3
2024
707
0.280
 Why?
Patient Readmission
1
2014
758
0.280
 Why?
Periodicals as Topic
2
2021
203
0.270
 Why?
Atrial Function, Left
2
2024
8
0.270
 Why?
Cost-Benefit Analysis
2
2024
634
0.270
 Why?
Body Mass Index
2
2025
2438
0.270
 Why?
Clinical Decision-Making
2
2021
359
0.260
 Why?
Physicians
1
2016
939
0.260
 Why?
Diagnosis, Computer-Assisted
2
2020
91
0.260
 Why?
Multicenter Studies as Topic
5
2024
405
0.260
 Why?
Logistic Models
5
2021
2117
0.260
 Why?
Myocardial Reperfusion
1
2007
59
0.260
 Why?
Cognition
3
2025
1266
0.250
 Why?
Administration, Intravenous
2
2025
170
0.250
 Why?
Enoxaparin
1
2007
67
0.250
 Why?
Sensitivity and Specificity
4
2020
1985
0.240
 Why?
Propanolamines
2
2017
40
0.240
 Why?
Voltage-Gated Sodium Channel Blockers
1
2026
7
0.240
 Why?
Adult
13
2025
40449
0.230
 Why?
Patient Participation
4
2025
431
0.230
 Why?
Lidocaine
1
2026
54
0.230
 Why?
Severity of Illness Index
4
2024
2925
0.230
 Why?
Cardiovascular Agents
1
2007
164
0.230
 Why?
Sleep Apnea, Obstructive
2
2020
300
0.220
 Why?
Equipment Failure
1
2025
115
0.220
 Why?
Inflammation
1
2016
2878
0.210
 Why?
Hospital Mortality
4
2026
1030
0.210
 Why?
Perioperative Care
3
2016
231
0.210
 Why?
Tachycardia, Supraventricular
1
2024
45
0.200
 Why?
Disease Progression
5
2022
2847
0.200
 Why?
Fee-for-Service Plans
2
2014
98
0.200
 Why?
Ambulatory Surgical Procedures
1
2024
80
0.200
 Why?
Cluster Analysis
2
2022
521
0.200
 Why?
Chi-Square Distribution
2
2015
529
0.200
 Why?
Cohort Studies
8
2021
5960
0.200
 Why?
Postoperative Complications
4
2025
2919
0.200
 Why?
Hospital Costs
1
2024
124
0.200
 Why?
Equipment Design
1
2025
530
0.200
 Why?
Quality Improvement
1
2012
1289
0.190
 Why?
Observational Studies as Topic
2
2014
129
0.190
 Why?
Physicians, Women
1
2024
88
0.190
 Why?
Macular Degeneration
1
2025
191
0.190
 Why?
Symptom Assessment
1
2024
137
0.190
 Why?
Cell Adhesion Molecules, Neuronal
1
2022
42
0.190
 Why?
Adonis
1
2022
1
0.190
 Why?
Cicatrix
2
2020
69
0.190
 Why?
Nerve Growth Factors
1
2022
78
0.180
 Why?
Brain Infarction
1
2022
23
0.180
 Why?
Medication Adherence
2
2019
539
0.180
 Why?
Esophageal Fistula
1
2022
21
0.180
 Why?
Magnetic Resonance Imaging
4
2020
3863
0.180
 Why?
Time-to-Treatment
1
2024
243
0.180
 Why?
Diabetes Mellitus
2
2022
1098
0.180
 Why?
Ablation Techniques
2
2019
36
0.180
 Why?
Hypertension
3
2023
1263
0.180
 Why?
Remote Sensing Technology
1
2022
19
0.180
 Why?
Prosthesis Design
1
2024
357
0.180
 Why?
Obesity
2
2025
3077
0.180
 Why?
Patient Preference
1
2024
224
0.180
 Why?
Fistula
1
2022
48
0.180
 Why?
Artificial Intelligence
2
2023
365
0.170
 Why?
Health Equity
1
2024
129
0.170
 Why?
Cardiac Catheterization
2
2020
560
0.170
 Why?
Inflammasomes
1
2022
146
0.170
 Why?
Thoracic Injuries
1
2022
72
0.170
 Why?
Perfusion
1
2022
250
0.170
 Why?
Disaccharides
1
2021
21
0.170
 Why?
Lactams
1
2021
28
0.170
 Why?
Cell Death
1
2022
383
0.170
 Why?
Societies, Medical
2
2017
887
0.170
 Why?
Transgender Persons
1
2024
191
0.170
 Why?
Research Report
1
2021
87
0.160
 Why?
Gadolinium
4
2022
84
0.160
 Why?
Receptors, Adrenergic, beta-1
2
2017
24
0.160
 Why?
Contrast Media
5
2022
488
0.160
 Why?
Adiposity
1
2025
543
0.160
 Why?
Esophagus
2
2022
261
0.160
 Why?
Health Services
1
2021
115
0.160
 Why?
Authorship
1
2020
49
0.160
 Why?
Contraindications, Drug
1
2019
10
0.150
 Why?
Kidney
2
2020
1495
0.150
 Why?
HMGB1 Protein
1
2019
51
0.150
 Why?
Social Class
1
2021
268
0.150
 Why?
Monitoring, Physiologic
1
2021
289
0.150
 Why?
Cell Membrane
1
2022
706
0.150
 Why?
Social Determinants of Health
1
2023
301
0.150
 Why?
DNA Demethylation
1
2018
4
0.140
 Why?
Esophageal Diseases
1
2018
30
0.140
 Why?
Telemetry
1
2018
41
0.140
 Why?
Feasibility Studies
2
2020
1095
0.140
 Why?
Natriuretic Peptide, Brain
1
2018
111
0.140
 Why?
Ventricular Dysfunction, Left
1
2021
392
0.140
 Why?
Metoprolol
1
2017
26
0.130
 Why?
Computer Systems
1
2017
56
0.130
 Why?
Sex Factors
2
2021
2112
0.130
 Why?
Drug Substitution
2
2017
63
0.130
 Why?
North Carolina
2
2014
128
0.130
 Why?
Evidence-Based Medicine
2
2021
732
0.130
 Why?
Recurrence
4
2024
1135
0.130
 Why?
Defibrillators
1
2017
23
0.130
 Why?
Reproducibility of Results
4
2020
3409
0.130
 Why?
Venous Thromboembolism
1
2021
324
0.130
 Why?
Choline O-Acetyltransferase
1
2016
25
0.120
 Why?
Nervous System Diseases
1
2020
284
0.120
 Why?
Hemostatic Techniques
1
2017
51
0.120
 Why?
Tertiary Care Centers
1
2017
189
0.120
 Why?
Data Collection
1
2019
633
0.120
 Why?
Hypertrophy, Left Ventricular
2
2015
124
0.120
 Why?
Reflex
1
2016
69
0.120
 Why?
Kaplan-Meier Estimate
2
2018
965
0.120
 Why?
Drug Prescriptions
1
2018
284
0.110
 Why?
Contraindications
1
2015
91
0.110
 Why?
Adrenergic beta-Antagonists
2
2015
250
0.110
 Why?
Hospitals, Community
1
2015
65
0.110
 Why?
Percutaneous Coronary Intervention
1
2020
543
0.110
 Why?
Renal Insufficiency, Chronic
1
2021
653
0.110
 Why?
Blood Pressure
2
2023
1769
0.110
 Why?
Intention to Treat Analysis
1
2014
80
0.100
 Why?
Odds Ratio
2
2013
1075
0.100
 Why?
Surveys and Questionnaires
2
2024
6048
0.100
 Why?
Emergencies
1
2015
175
0.100
 Why?
Cardiology
1
2017
353
0.100
 Why?
Animals
7
2022
38058
0.100
 Why?
Ventilator-Induced Lung Injury
1
2014
61
0.100
 Why?
Premedication
1
2013
42
0.100
 Why?
Double-Blind Method
2
2017
2029
0.100
 Why?
Ischemic Attack, Transient
1
2014
71
0.100
 Why?
Epigenesis, Genetic
1
2018
684
0.100
 Why?
Ticlopidine
1
2013
54
0.100
 Why?
Coronary Disease
2
2006
383
0.100
 Why?
Accreditation
1
2013
101
0.100
 Why?
Gene Expression Regulation, Developmental
1
2018
905
0.100
 Why?
Quality of Health Care
2
2019
691
0.100
 Why?
Thrombosis
1
2017
393
0.090
 Why?
Primary Prevention
1
2014
220
0.090
 Why?
Drug Synergism
1
2013
357
0.090
 Why?
Operating Rooms
1
2014
146
0.090
 Why?
Cerebrovascular Disorders
1
2013
103
0.090
 Why?
Calcium Channel Blockers
1
2013
165
0.090
 Why?
Peripheral Arterial Disease
1
2019
503
0.090
 Why?
Models, Cardiovascular
1
2013
195
0.090
 Why?
Atrioventricular Block
1
2012
45
0.090
 Why?
Electronics
2
2023
71
0.090
 Why?
Critical Illness
1
2018
891
0.090
 Why?
Ventricular Remodeling
1
2014
276
0.090
 Why?
Cross-Sectional Studies
2
2021
5868
0.090
 Why?
Clinical Trials, Phase II as Topic
2
2024
77
0.090
 Why?
Myocardial Ischemia
1
2013
285
0.090
 Why?
Depression
1
2021
1558
0.090
 Why?
Diagnostic Imaging
1
2014
338
0.090
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2013
257
0.080
 Why?
Continuity of Patient Care
1
2013
291
0.080
 Why?
Risk
1
2013
911
0.080
 Why?
International Normalized Ratio
2
2021
49
0.080
 Why?
CD4-Positive T-Lymphocytes
1
2016
1129
0.080
 Why?
Glomerular Filtration Rate
1
2013
760
0.080
 Why?
Kidney Diseases
1
2013
427
0.080
 Why?
Liver
1
2018
1887
0.070
 Why?
Mice
3
2022
18339
0.070
 Why?
Respiration, Artificial
1
2014
708
0.070
 Why?
Socioeconomic Factors
1
2013
1326
0.070
 Why?
Patient Education as Topic
1
2013
780
0.070
 Why?
Databases, Factual
2
2025
1486
0.070
 Why?
Retreatment
1
2007
77
0.060
 Why?
Referral and Consultation
1
2013
851
0.060
 Why?
Thinness
1
2025
99
0.060
 Why?
Health Knowledge, Attitudes, Practice
1
2013
1414
0.050
 Why?
Signal Transduction
1
2018
5226
0.050
 Why?
Cardiologists
1
2024
47
0.050
 Why?
Pragmatic Clinical Trials as Topic
1
2024
133
0.050
 Why?
Tomography, X-Ray Computed
1
2014
2730
0.050
 Why?
Drug Therapy, Combination
2
2019
1047
0.050
 Why?
Gender Identity
1
2024
121
0.050
 Why?
Syncope
1
2023
55
0.050
 Why?
Magnetic Resonance Imaging, Cine
1
2024
214
0.050
 Why?
Echocardiography
1
2025
652
0.050
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
439
0.050
 Why?
Vena Cava, Superior
1
2022
25
0.050
 Why?
Dizziness
1
2023
101
0.040
 Why?
Career Choice
1
2024
237
0.040
 Why?
Mentors
1
2024
219
0.040
 Why?
Flecainide
1
2021
8
0.040
 Why?
Reoperation
1
2024
630
0.040
 Why?
Age of Onset
1
2023
551
0.040
 Why?
Dyspnea
1
2023
251
0.040
 Why?
Peptide Fragments
1
2005
699
0.040
 Why?
Chicago
1
2020
61
0.040
 Why?
Device Removal
1
2022
143
0.040
 Why?
Psychometrics
1
2024
734
0.040
 Why?
Atrial Remodeling
1
2020
10
0.040
 Why?
Current Procedural Terminology
1
2020
19
0.040
 Why?
Seasons
1
2023
556
0.040
 Why?
Meglumine
1
2020
18
0.040
 Why?
Emergency Service, Hospital
1
2012
2310
0.040
 Why?
Aftercare
1
2022
223
0.040
 Why?
Temperature
1
2023
679
0.040
 Why?
Intracranial Embolism
1
2019
34
0.040
 Why?
Cells, Cultured
2
2018
4154
0.040
 Why?
Phenotype
2
2018
3162
0.040
 Why?
Forecasting
1
2021
391
0.040
 Why?
Propensity Score
1
2021
367
0.040
 Why?
Education, Medical, Graduate
1
2024
557
0.040
 Why?
International Classification of Diseases
1
2020
147
0.040
 Why?
Heart
1
2023
636
0.040
 Why?
Myocardial Revascularization
1
2019
85
0.040
 Why?
Peripheral Vascular Diseases
1
2019
104
0.040
 Why?
Hyperlipidemias
1
2019
122
0.040
 Why?
Organometallic Compounds
1
2020
112
0.040
 Why?
Support Vector Machine
1
2018
36
0.040
 Why?
Kidney Failure, Chronic
1
2005
598
0.040
 Why?
Peripheral Nervous System Diseases
1
2019
133
0.040
 Why?
5-Methylcytosine
1
2018
25
0.030
 Why?
Dioxygenases
1
2018
36
0.030
 Why?
Self-Management
1
2021
201
0.030
 Why?
Patient Safety
1
2021
347
0.030
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2017
18
0.030
 Why?
Asymptomatic Diseases
1
2018
102
0.030
 Why?
Consensus
1
2020
488
0.030
 Why?
Diffusion of Innovation
1
2018
98
0.030
 Why?
Primary Cell Culture
1
2018
173
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2017
117
0.030
 Why?
Systole
1
2017
178
0.030
 Why?
Models, Biological
1
2025
1821
0.030
 Why?
Hepatocytes
1
2018
223
0.030
 Why?
Cognitive Dysfunction
1
2023
461
0.030
 Why?
ROC Curve
1
2018
614
0.030
 Why?
Mortality
1
2019
375
0.030
 Why?
Feedback, Physiological
1
2016
83
0.030
 Why?
Mice, Inbred C57BL
2
2018
5992
0.030
 Why?
Longitudinal Studies
1
2023
2947
0.030
 Why?
Sequence Analysis, RNA
1
2018
442
0.030
 Why?
Animals, Newborn
1
2018
902
0.030
 Why?
Proto-Oncogene Proteins
1
2018
623
0.030
 Why?
Genetic Testing
1
2017
478
0.030
 Why?
Patient Satisfaction
1
2019
704
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2018
549
0.030
 Why?
District of Columbia
1
2014
36
0.030
 Why?
Decision Making
1
2022
975
0.030
 Why?
Pandemics
1
2022
1694
0.030
 Why?
Pharmacogenetics
1
2015
172
0.030
 Why?
Abdomen
1
2014
141
0.020
 Why?
Internship and Residency
1
2024
1257
0.020
 Why?
Costs and Cost Analysis
1
2014
219
0.020
 Why?
Genotype
1
2017
1833
0.020
 Why?
Machine Learning
1
2018
585
0.020
 Why?
Insurance Coverage
1
2014
239
0.020
 Why?
Polymorphism, Genetic
1
2015
612
0.020
 Why?
Ambulatory Care
1
2016
600
0.020
 Why?
Mice, Knockout
1
2018
3121
0.020
 Why?
DNA
1
2017
1463
0.020
 Why?
DNA-Binding Proteins
1
2018
1499
0.020
 Why?
Rats
1
2019
5597
0.020
 Why?
Patient Compliance
1
2014
588
0.020
 Why?
Genetic Predisposition to Disease
1
2018
2363
0.020
 Why?
Disease Models, Animal
1
2019
4557
0.020
 Why?
Young Adult
1
2024
14105
0.020
 Why?
Biomarkers
1
2018
4271
0.020
 Why?
Syndrome
1
2006
380
0.010
 Why?
Hirudins
1
2005
51
0.010
 Why?
Adolescent
1
2024
22428
0.010
 Why?
Kidney Function Tests
1
2005
157
0.010
 Why?
Creatinine
1
2005
506
0.010
 Why?
Recombinant Proteins
1
2005
1370
0.010
 Why?
Steinberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (410) concept(s)
_
Co-Authors Expand Description
See all (6) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)